News Search & Analytics
US Edition
Minimum 3 characters required!!
Report Based On Past 7 Days Data
14
Total Articles
11
Total Publisher Covering articles
6
Highest On 2017-09-20
0
Articles Got Popular On Social Media
advanced cancer treatment found in Articles in last 7 Days

Top Articles

Updated 27 minutes ago Allegheny Health Network and Johns Hopkins have launched a clinical trial to find out whether Opdivo, a popular immunotherapy drug, might be an effective tre...
Medical News Today: Immunotherapy for lung cancer: What you need to know
-Medical News Today - Mon Sep 18 05:42:56 EDT 2017
This treatment option uses medicines to stimulate the body's immune system so that it can fight the cancer cells more effectively. Immunotherapy has changed the way doctors treat m...
Life-extending lung cancer drug approved
-BBC News - Tue Sep 19 17:10:15 EDT 2017
A life-extending lung cancer drug will be made immediately available to NHS patients in England, say advisers. Campaigners, including the late Sunday Times restaurant critic AA Gil...
SAN DIEGO — Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or two w...
Pharma Companies Are Overpricing Cancer Drugs, Says New Study
-Wall Street Pit - Sun Sep 17 08:03:02 EDT 2017
According to the National Cancer Institute, “approximately 38.5 percent of men and women will be diagnosed with cancer of any site at some point during their lifetime based on...
PHILADELPHIA -- (Sept. 19, 2017) -- In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified ...
Medical News Today: Lung cancer and cough: What is the connection?
-Medical News Today - Mon Sep 18 05:10:03 EDT 2017
Despite these problems, coughing actually serves a very valuable and useful purpose. Coughing is a protective action, helping the lungs clear out potential germs or harmful objects...
Will cancer immune therapy work for you?
-tribLive - Wed Sep 20 20:00:25 EDT 2017
In this March 1, 2017, photo, Dennis Lyon sits outside the University of California, San Diego’s Moores Cancer Center, where he was treated for an unusual skin cancer that had spre...
The big question: Will cancer immune therapy work for me?
-The Seattle Times - Tue Sep 19 23:06:16 EDT 2017
SAN DIEGO (AP) — Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or ...
The big question: Will cancer immune therapy work for me?
-Stat News - Wed Sep 20 08:12:01 EDT 2017
S AN DIEGO — Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or two ...
The big question: Will cancer immune therapy work for me?
-News-Sentinel.com - Tue Sep 19 23:00:25 EDT 2017
SAN DIEGO — Dennis Lyon was a genetic train wreck. Cancer was ravaging his liver, lungs, bones and brain, and tests showed so many tumor mutations that drugs targeting one or two w...
Trump Blocks Woman With Stage 4 Cancer On Twitter After Health Care Critiques
-International Business Times - Wed Sep 20 11:09:29 EDT 2017
President Donald Trump blocked on Twitter a Nevada woman with advanced cancer after she began tweeting at him different criticisms of Republican health care bills, according to Thi...
Novartis's Rydapt wins EU approval for AML, other diseases
-Reuters - Wed Sep 20 08:10:36 EDT 2017
ZURICH (Reuters) - Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML) and other rare dis...
Novartis's Rydapt wins EU approval for AML, other diseases
-Reuters - Thu Sep 21 08:11:53 EDT 2017
ZURICH (Reuters) - Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML) and other rare dis...
Juno Therapeutics ready for another round in war on cancer
-The Seattle Times - Fri Sep 15 11:07:27 EDT 2017
When his second round of chemotherapy failed, physicians told Dan Symes that he had only a few more months to live. Symes, a 66-year-old former construction worker from Boston, had...
Juno Therapeutics ready for another round in war on cancer
-The Seattle Times - Fri Sep 15 11:20:29 EDT 2017
When his second round of chemotherapy failed, physicians told Dan Symes that he had only a few more months to live. Symes, a 66-year-old former construction worker from Boston, had...
How affirmative action could cure cancer and heart disease
-The Conversation - Fri Sep 15 02:35:13 EDT 2017
Affirmative action programs are designed to provide access to high-quality higher education for underrepresented minorities, but the Trump administration is targeting these essenti...
Why We Fight and Punish: A Q&A With Robert Sapolsky
-Reason - Fri Sep 15 08:06:28 EDT 2017
Robert Sapolsky. Photo credit: Stanford University"The current state of the country and the current state of political and intellectual conversation depresses me in a way that it n...
Advertisement